We are live on ! Find out more
MRNS

Marinus Pharmaceuticals, Inc
MRNS

Delisted

MRNS was delisted on the 10th of February, 2025.

Back to rankings

Fund managers haven’t disclosed any holdings of MRNS yet.

MRNS Hedge Fund Activity: Q1 2025 in Review

0 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Marinus Pharmaceuticals, Inc (MRNS) for Q1 2025, worth a combined $0 — down 100% from $15.8M a quarter earlier.

Sellers outnumbered buyers: 53 funds closed out of MRNS and 0 opened new positions — a net loss of 53 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Beryl Capital Management, exiting entirely with an estimated $2.26M sold.

  • 0 institutional investors held Marinus Pharmaceuticals, Inc (MRNS) as of Q1 2025, down from 53 in Q4 2024.
  • Funds reported $0 of Marinus Pharmaceuticals, Inc stock for Q1 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Marinus Pharmaceuticals, Inc positions in Q1 2025 and 53 closed out, a net change of -53 holders.
  • The largest Marinus Pharmaceuticals, Inc seller in Q1 2025 was Beryl Capital Management, an estimated $2.26M sold.

Based on aggregated 13F filings for Q1 2025.